The Food and Drug Administration (FDA) is announcing the renewal of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the Pharmaceutical Science and Clinical Pharmacology Advisory Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect until January 22, 2020.
Document
Advisory Committee; Pharmaceutical Science and Clinical Pharmacology Advisory Committee, Renewal
The Food and Drug Administration (FDA) is announcing the renewal of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee by the Commissioner of Food and Drugs...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
83 FR 3736
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Advisory Committee; Pharmaceutical Science and Clinical Pharmacology Advisory Committee, Renewal,” thefederalregister.org (January 26, 2018), https://thefederalregister.org/documents/2018-01377/advisory-committee-pharmaceutical-science-and-clinical-pharmacology-advisory-committee-renewal.